Solution-Phase Parallel Synthesis of N-Substituted Isoquinuclidines

M. S. Levi; M. O.F. Khan; R. F. Borne

doi:10.2174/1570180043398597

ISSN: 1570-1808
E-ISSN: 1875-628X

Solution-Phase Parallel Synthesis of N-Substituted Isoquinuclidines
Authors: M. S. Levi¹, M. O.F. Khan² and R. F. Borne³
View Affiliations Hide Affiliations

¹ Department of Medicinal Chemistry and Laboratory for Applied Drug Design and Synthesis, School of Pharmacy, University of Mississippi, University, MS 38677, USA. ² Department of Medicinal Chemistry and Laboratory for Applied Drug Design and Synthesis, School of Pharmacy, University of Mississippi, University, MS 38677, USA. ³ Department of Medicinal Chemistry and Laboratory for Applied Drug Design and Synthesis, School of Pharmacy, University of Mississippi, University, MS 38677, USA.
Source: Letters in Drug Design & Discovery, Volume 1, Issue 4, Oct 2004, p. 384 - 386
DOI: https://doi.org/10.2174/1570180043398597
- Available online: 01 Oct 2004

Abstract

The naturally-occurring alkaloid ibogaine, found in the West African shrub Tabernanthe iboga, possesses the ability to diminish self-administration of substances of abuse, such as cocaine, heroin and alcohol. This was the lead structure for the design of a 16-member library of N-substituted isoquinuclidines. A solution-phase method for their synthesis is described.

Article metrics loading...

/content/journals/lddd/10.2174/1570180043398597

2004-10-01

2025-09-02

From This Site

/content/journals/lddd/10.2174/1570180043398597

dcterms_title,dcterms_subject,pub_keyword

-contentType:Contributor -contentType:Concept -contentType:Institution

10

5

Full text loading...

/content/journals/lddd/10.2174/1570180043398597

Article Type: Review Article

Keyword(s): 2-azabicyclo[2.2.2]octanes; drug dependence; Ibogaine; isoquinuclidines; parallel synthesis

Solution-Phase Parallel Synthesis of N-Substituted Isoquinuclidines

Abstract

From This Site

Most Read This Month

Most Cited Most Cited RSS feed

Discovery, Structural Determination and Anticancer Activities of Lactucinlike Guaianolides

Thermodynamic Aspects of Cancer: Possible Role of Negative Entropy in Tumor Growth, its Relation to Kinetic and Genetic Resistance

Immunomodulatory Properties of Synthetic Imidazolone Derivatives

Design and Prediction of ADME/Tox Properties of Novel Magnolol Derivatives as Anticancer Agents for NSCLC Using 3D-QSAR, Molecular Docking, MOLCAD and MM-GBSA Studies

Redox Active Iron at the Center of Oxidative Stress in Alzheimer Disease

Identifying Protein Binding Sites and Optimal Ligands

Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part I: Amides and Ureas

Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part II: Sulfonamides

Selection of a Catalytically Active Enzyme In Vivo Via Phage Display of its Product

A Comprehensive Review of the Advancement in Omic Technologies in the Field of Drug Discovery and Development